PHA-Exch> Pharmaceutical Pricing Policies in a Global Market

[Claudio Schuftan]

--From: Ruggiero, Mrs. Ana Lucia (WDC) <ruglucia at paho.org>
crossposted from: EQUIDAD at listserv.paho.org


 *Pharmaceutical Pricing Policies in a Global Market*

*OECD Health Policy Studies - Directorate for Employment, Labour and Social
Affairs, Health Division
September 2008*

*Pharmaceutical pricing policies are designed with national objectives in
mind, but are the transnational implications always taken into account?*

Executive summary: http://www.oecd.org/dataoecd/36/2/41303903.pdf

OECD website:
http://www.oecd.org/document/36/0,3343,en_2649_33929_41000996_1_1_1_37407,00.html


"….This report assesses how pharmaceutical pricing and reimbursement
policies have contributed to the achievement of certain health policy
objectives. It examines the national and transnational effects of these
policies, in particular, their implications for the availability of
medicines in other countries, the prices of these medicines, and innovation
in the pharmaceutical sector.

This publication presents an analysis of comparative price levels, making
use of a unique dataset to construct the most comprehensive pan-OECD
pharmaceutical price index to date. It also draws upon original case studies
of pharmaceutical pricing and reimbursement policies in six OECD countries
to provide specific examples of the impacts of policies on health system
performance The latest comparable data and trends on different aspects of
the performance of health systems in OECD countries…."



*Table of Contents*

*Executive Summary**
**Introduction**
**Chapter 1. Key Characteristics of the Pharmaceutical Sector in OECD
Economies***

*Chapter 2. The Pharmaceutical Industry and its Activities***

*Chapter 3. Pharmaceutical Pricing and Reimbursement and the Broader
Pharmaceutical Policy***

*Chapter 4. The Impact of Pharmaceutical Pricing Policies on Performance in
Meeting Health Policy Goals***

*Chapter 5. The Impact of National Pricing and Reimbursement Practices on
Prices and Availability of Medicines in Other Countries***

*Chapter 6. The Impact of Pharmaceutical Pricing Policies on Pharmaceutical
Innovation*

* *

* *
-------------- next part --------------
An HTML attachment was scrubbed...
URL: <http://phm.phmovement.org/pipermail/phm-exchange-phmovement.org/attachments/20080930/805625d5/attachment-0001.html>